Biotech company Moderna announced on Tuesday that its coronavirus vaccine candidate elicited immune responses in older adults from a Phase 1 study in levels comparable to those seen in younger adults.
Moderna Coronavirus Vaccine
Comment
Show comments
Hide Comments
